{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:37:12Z","timestamp":1770511032160,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12883-015-0431-0","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T21:38:14Z","timestamp":1443044294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine)"],"prefix":"10.1186","volume":"15","author":[{"given":"Philipp M.","family":"Keune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Cocks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina M.","family":"Burschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Hofstadt-van Oy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Oschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Muenssinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"431_CR1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502\u201317.","journal-title":"Lancet"},{"key":"431_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrneurol.2012.136","volume":"8","author":"RW Motl","year":"2012","unstructured":"Motl RW, Pilutti LA. The benefits of exercise training in multiple sclerosis. Nat Rev Neurol. 2012;8:487\u201397.","journal-title":"Nat Rev Neurol"},{"key":"431_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2377-12-161","volume":"12","author":"JM Burschka","year":"2012","unstructured":"Burschka JM, Keune PM, Menge U, Hofstadt-van Oy U, Oschmann P, Hoos O. An exploration of impaired walking dynamics and fatigue in multiple sclerosis. BMC Neurol. 2012;12:161.","journal-title":"BMC Neurol"},{"key":"431_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12883-014-0165-4","volume":"14","author":"JM Burschka","year":"2014","unstructured":"Burschka JM, Keune PM, Oy UH, Oschmann P, Kuhn P. Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression. BMC Neurol. 2014;14:165.","journal-title":"BMC Neurol"},{"key":"431_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1352458512463769","volume":"19","author":"AV Krishnan","year":"2013","unstructured":"Krishnan AV, Kiernan MC. Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis. Mult Scler. 2013;19:385\u201391.","journal-title":"Mult Scler"},{"key":"431_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1756285613512712","volume":"7","author":"HB Jensen","year":"2014","unstructured":"Jensen HB, Ravnborg M, Dalgas U, Stenager E. 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review. Ther Adv Neurol Disord. 2014;7:97\u2013113.","journal-title":"Ther Adv Neurol Disord"},{"key":"431_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.12512","volume":"1329","author":"AR Blight","year":"2014","unstructured":"Blight AR, Henney HR, Cohen R. Development of dalfampridine, a novel pharmacologic approach for treating walking impairment in multiple sclerosis. Ann N Y Acad Sci. 2014;1329:33\u201344.","journal-title":"Ann N Y Acad Sci"},{"key":"431_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1212\/WNL.44.6.1054","volume":"44","author":"CT Bever","year":"1994","unstructured":"Bever CT, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, et al. The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology. 1994;44:1054\u20139.","journal-title":"Neurology"},{"key":"431_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/135245850100700602","volume":"7","author":"PM Rossini","year":"2001","unstructured":"Rossini PM, Pasqualetti P, Pozzilli C, Grasso MG, Millefiorini E, Graceffa A, et al. Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler. 2001;7:354\u20138.","journal-title":"Mult Scler"},{"key":"431_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/WNL.48.4.817","volume":"48","author":"SR Schwid","year":"1997","unstructured":"Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology. 1997;48:817\u201321.","journal-title":"Neurology"},{"key":"431_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1352458506069538","volume":"13","author":"AD Goodman","year":"2007","unstructured":"Goodman AD, Cohen JA, Cross A, Vollmer T, Rizzo M, Cohen R, et al. Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Mult Scler. 2007;13:357\u201368.","journal-title":"Mult Scler"},{"key":"431_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.wnl.0000326213.89576.0e","volume":"71","author":"AD Goodman","year":"2008","unstructured":"Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, et al. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 2008;71:1134\u201341.","journal-title":"Neurology"},{"key":"431_CR13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0140-6736(09)60442-6","volume":"373","author":"AD Goodman","year":"2009","unstructured":"Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009;373:732\u20138.","journal-title":"Lancet"},{"key":"431_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ana.22240","volume":"68","author":"AD Goodman","year":"2010","unstructured":"Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, et al. A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. Ann Neurol. 2010;68:494\u2013502.","journal-title":"Ann Neurol"},{"key":"431_CR15","doi-asserted-by":"crossref","unstructured":"Hupperts R, Lycke J, Short C, Gasperini C, McNeill M, Medori R, et al. Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial. Mult Scler. 2015.","DOI":"10.1177\/1352458515581436"},{"key":"431_CR16","volume-title":"Multiple Sclerosis Functional Composite (MSFC): administration and scoring manual","author":"JS Fischer","year":"2001","unstructured":"Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Multiple Sclerosis Functional Composite (MSFC): administration and scoring manual. New York: National Multiple Sclerosis Society; 2001."},{"key":"431_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/1352458512444498","volume":"18","author":"BC Kieseier","year":"2012","unstructured":"Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012;18:914\u201324.","journal-title":"Mult Scler"},{"key":"431_CR18","first-page":"59","volume":"49","author":"RW Motl","year":"2013","unstructured":"Motl RW, Balantrapu S, Pilutti L, Dlugonski D, Suh Y, Sandroff BM, et al. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis. Eur J Phys Rehabil Med. 2013;49:59\u201366.","journal-title":"Eur J Phys Rehabil Med"},{"key":"431_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2377-12-6","volume":"12","author":"RW Motl","year":"2012","unstructured":"Motl RW, Suh Y, Balantrapu S, Sandroff BM, Sosnoff JJ, Pula J, et al. Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis. BMC Neurol. 2012;12:6.","journal-title":"BMC Neurol"},{"key":"431_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/1352458507082607","volume":"14","author":"MD Goldman","year":"2008","unstructured":"Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008;14:383\u201390.","journal-title":"Mult Scler"},{"key":"431_CR21","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/09638280500164479","volume":"27","author":"S Savci","year":"2005","unstructured":"Savci S, Inal-Ince D, Arikan H, Guclu-Gunduz A, Cetisli-Korkmaz N, Armutlu K, et al. Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disabil Rehabil. 2005;27:1365\u201371.","journal-title":"Disabil Rehabil"},{"key":"431_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.rmed.2003.11.011","volume":"98","author":"A Chetta","year":"2004","unstructured":"Chetta A, Rampello A, Marangio E, Merlini S, Dazzi F, Aiello M, et al. Cardiorespiratory response to walk in multiple sclerosis patients. Respir Med. 2004;98:522\u20139.","journal-title":"Respir Med"},{"key":"431_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121\u20137.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0431-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-015-0431-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-015-0431-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T18:42:49Z","timestamp":1567190569000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-015-0431-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["431"],"URL":"https:\/\/doi.org\/10.1186\/s12883-015-0431-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]},"article-number":"171"}}